Brief: Clearmind Medicine Secured Exclusive Global Rights To Innovative Psychedelic Compounds For PTSD Treatment
20/06/2024 13:28
June 20 (Reuters) - Clearmind Medicine Inc CMND.O :
* CLEARMIND MEDICINE INC - SECURED EXCLUSIVE GLOBAL RIGHTS
TO
INNOVATIVE PSYCHEDELIC COMPOUNDS FOR PTSD TREATMENT
* CLEARMIND MEDICINE INC - SIGNED AN EXCLUSIVE PATENT
LICENSING
AGREEMENT WITH YISSUM RESEARCH DEVELOPMENT COMPANY OF HEBREW
UNIVERSITY OF JERUSALEM
Source text for Eikon: ID:nGNX9Fpmlf
Further company coverage: CMND.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearmind Medicine
See all newsBrief: Clearmind Advances Dialogue With U.S. Federal Government On Psychedelic Therapies, Submitting Recommendations To FDA
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM